Jan Jacob Schuringa

25PUBLICATIONS
83CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsNutrigenomics and personalised nutritionMedical mycologyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Mar 25, 2026
Autophagy inhibition potentiates the antileukemic effect of FLT3 inhibitors and overcomes resistance in FLT3-ITD acute myeloid leukemia.

Manuela Albuquerque de Melo, Brunno Gilberto Santos de Macedo, Diego A Pereira-Martins

|Oct 31, 2025
Metformin induces ferroptosis associated with lipidomic remodeling in AML.

Dominique Sternadt, Diego A Pereira-Martins, Prodromos Chatzikyriakou

|Mar 17, 2025
Lactate dehydrogenase A-coupled NAD+ regeneration is critical for acute myeloid leukemia cell survival.

Ayşegül Erdem, Séléna Kaye, Francesco Caligiore

|Dec 24, 2024
Menin inhibitors in the treatment of acute myeloid leukemia.

Gerwin Huls, Carolien M Woolthuis, Jan Jacob Schuringa

|Jun 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias.

Min Chul Kwon, Jan Willem Thuring, Olivier Querolle

|Oct 31, 2023
The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia.

Alan Cunningham, Lieve L Oudejans, Marjan Geugien

Pageof 5

Frequent Collaborators

4 joint publications

Diego Pereira-Martins

4 joint publications

Shanna M Hogeling

3 joint publications

Isabelle A van Zeventer

2 joint publications

Bert A van der Reijden